FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Tuesday reported a loss of $45.1 million in its second quarter.
The Fort Myers, Florida-based company said it had a loss of 35 cents per share. Earnings, adjusted for asset impairment costs and stock option expense, were 3 cents per share.
The results met Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for earnings of 3 cents per share.
The operator of cancer-focused testing laboratories posted revenue of $181.3 million in the period, falling short of Street forecasts. Seven analysts surveyed by Zacks expected $182.9 million.
NeoGenomics expects full-year earnings in the range of 8 cents to 12 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEO at https://www.zacks.com/ap/NEO
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
